PMID- 33672928 OWN - NLM STAT- MEDLINE DCOM- 20210419 LR - 20211204 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 22 IP - 4 DP - 2021 Feb 14 TI - Low-Temperature Argon Plasma Regulates Skin Moisturizing and Melanogenesis-Regulating Markers through Yes-Associated Protein. LID - 10.3390/ijms22041895 [doi] LID - 1895 AB - Extensive water loss and melanin hyperproduction can cause various skin disorders. Low-temperature argon plasma (LTAP) has shown the possibility of being used for the treatment of various skin diseases, such as atopic dermatitis and skin cancer. However, the role of LTAP in regulating skin moisturizing and melanogenesis has not been investigated. In this study, we aimed to determine the effect of LTAP on yes-associated protein (YAP), a major transcriptional coactivator in the Hippo signaling pathway that is involved in skin moisturizing and melanogenesis-regulating markers. In normal human epidermal keratinocytes (NHEKs), the human epidermal keratinocyte line HaCaT, and human dermal fibroblasts (HDFs), we found that LTAP exhibited increased expression levels of YAP protein. In addition, the expression levels of filaggrin (FLG), which is involved in natural moisturizing factors (NMFs), and hyaluronic acid synthase (HAS), transglutaminase (TGM), and involucrin (IVL), which regulate skin barrier and moisturizing, were also increased after exposure to LTAP. Furthermore, collagen type I alpha 1 and type III alpha 1 (COL1A1, COL3A1) were increased after LTAP exposure, but the expression level of matrix metalloproteinase-3 (MMP-3) was reduced. Moreover, LTAP was found to suppress alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenesis in murine melanoma B16F10 cells and normal human melanocytes (NHEMs). LTAP regulates melanogenesis of the melanocytes through decreased YAP pathway activation in a melanocortin 1 receptor (MC1R)-dependent manner. Taken together, our data show that LTAP regulates skin moisturizing and melanogenesis through modulation of the YAP pathway, and the effect of LTAP on the expression level of YAP varies from cell to cell. Thus, LTAP might be developed as a treatment method to improve the skin barrier, moisture content, and wrinkle formation, and to reduce melanin generation. FAU - Kim, Hae-Young AU - Kim HY AD - Department of Dermato-Immunology, College of Medicine, Catholic University of Korea, Seoul 06591, Korea. FAU - Agrahari, Gaurav AU - Agrahari G AUID- ORCID: 0000-0003-0407-7083 AD - Department of Dermato-Immunology, College of Medicine, Catholic University of Korea, Seoul 06591, Korea. FAU - Lee, Min Jung AU - Lee MJ AD - Department of Dermato-Immunology, College of Medicine, Catholic University of Korea, Seoul 06591, Korea. FAU - Tak, Lee-Jung AU - Tak LJ AD - Department of Dermato-Immunology, College of Medicine, Catholic University of Korea, Seoul 06591, Korea. FAU - Ham, Won-Kook AU - Ham WK AD - Department of Dermato-Immunology, College of Medicine, Catholic University of Korea, Seoul 06591, Korea. FAU - Kim, Tae-Yoon AU - Kim TY AD - Department of Dermato-Immunology, College of Medicine, Catholic University of Korea, Seoul 06591, Korea. LA - eng GR - 2016M3A9B6903020/National Research Foundation of Korea/ PT - Journal Article DEP - 20210214 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (COL1A1 protein, human) RN - 0 (Collagen Type I, alpha 1 Chain) RN - 0 (FLG protein, human) RN - 0 (Filaggrin Proteins) RN - 0 (Melanins) RN - 0 (Plasma Gases) RN - 0 (Receptor, Melanocortin, Type 1) RN - 0 (Transcription Factors) RN - 0 (YAP-Signaling Proteins) RN - 0 (YAP1 protein, human) RN - 581-05-5 (alpha-MSH) RN - 67XQY1V3KH (Argon) SB - IM MH - Adaptor Proteins, Signal Transducing/*metabolism MH - Animals MH - Argon/*pharmacology MH - Cell Line MH - Cell Line, Tumor MH - Cells, Cultured MH - Collagen Type I, alpha 1 Chain MH - Filaggrin Proteins MH - Humans MH - Keratinocytes/cytology/drug effects/metabolism MH - Melanins/*metabolism MH - Melanocytes/cytology/drug effects/metabolism MH - Mice MH - Plasma Gases/*pharmacology MH - Receptor, Melanocortin, Type 1/metabolism MH - Skin/*drug effects/metabolism MH - Skin Aging/drug effects MH - Temperature MH - Transcription Factors/*metabolism MH - YAP-Signaling Proteins MH - alpha-MSH/metabolism PMC - PMC7918577 OTO - NOTNLM OT - low-temperature argon plasma OT - melanogenesis OT - melanoma OT - skin barrier OT - skin moisturizing OT - yes-associated protein COIS- The authors have no conflict of interest to declare. EDAT- 2021/03/07 06:00 MHDA- 2021/04/20 06:00 PMCR- 2021/02/14 CRDT- 2021/03/06 01:14 PHST- 2020/12/18 00:00 [received] PHST- 2021/02/01 00:00 [revised] PHST- 2021/02/03 00:00 [accepted] PHST- 2021/03/06 01:14 [entrez] PHST- 2021/03/07 06:00 [pubmed] PHST- 2021/04/20 06:00 [medline] PHST- 2021/02/14 00:00 [pmc-release] AID - ijms22041895 [pii] AID - ijms-22-01895 [pii] AID - 10.3390/ijms22041895 [doi] PST - epublish SO - Int J Mol Sci. 2021 Feb 14;22(4):1895. doi: 10.3390/ijms22041895.